The keys to R&D: The rise of enterprise asset management in the pharma industry

Lorenzo Nanetti; Michael J. Desabris

The keys to R&D: The rise of enterprise asset management in the pharma industry

Lorenzo Nanetti, Michael J. Desabris

Fondazione IRCCS Istituto Neurologico "C. Besta"

Research output: Contribution to journal › Article › peer-review

Abstract

The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.

Original language	English
Pages (from-to)	8-11
Number of pages	4
Journal	European Pharmaceutical Contractor
Issue number	SPRING
Publication status	Published - Mar 2004

ASJC Scopus subject areas

Pharmaceutical Science

Fingerprint Dive into the research topics of 'The keys to R&D: The rise of enterprise asset management in the pharma industry'. Together they form a unique fingerprint.

Cite this

@article{48bf4b9e66bd4f1facc2c3b6b04fe029,

title = "The keys to R&D: The rise of enterprise asset management in the pharma industry",

abstract = "The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.",

author = "Lorenzo Nanetti and Desabris, {Michael J.}",

year = "2004",

month = mar,

language = "English",

pages = "8--11",

journal = "EPC - European Pharmaceutical Contractor",

issn = "1364-369X",

publisher = "Samedan Ltd",

number = "SPRING",

}

TY - JOUR

T1 - The keys to R&D

T2 - The rise of enterprise asset management in the pharma industry

AU - Nanetti, Lorenzo

AU - Desabris, Michael J.

PY - 2004/3

Y1 - 2004/3

N2 - The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.

AB - The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.

UR - http://www.scopus.com/inward/record.url?scp=4444252005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444252005&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:4444252005

SP - 8

EP - 11

JO - EPC - European Pharmaceutical Contractor

JF - EPC - European Pharmaceutical Contractor

SN - 1364-369X

IS - SPRING

ER -